icon-menu
icon-menu

Products

La–Son, 25 mg tablets

Drug formTablets

ATC categoryNeurology. Psychiatry

ATC subcategoryAnxiolytics

Brand nameLa–Son

Generic nameНydroxyzine

Qualitative and quantitative composition

Each tablet contains:

Active ingredient: Hydroxyzine hydrochloride – 25 mg;

For a full list of excipients, see section List of excipients.

Posology and method of administration

Posology

La-Son should be used at the lowest effective dose and for the shortest possible duration. In adults and children over 40 kg in weight, the maximum daily dose is 100 mg per day.

Anxiety

Adults

50-100mg daily in divided doses

 

Pruritus

Adults

Starting dose of 25mg at night increasing as necessary to 25mg three or four times daily.

Elderly 

In the elderly, the maximum daily dose is 50 mg per day (see section Special warnings and precautions for use). A reduced dose is advised. This is due to a possible increase in the volume of distribution, prolonged action and the possible effect of age-related changes on pharmacologic functions; including hepatic metabolism and renal excretion (see Section ‘Pharmacokinetic properties’)

Paediatric Population

For treating itching in children

This product is not recommended for children under 6 years of age. In children up to 40 kg in weight, other appropriate strengths and dosage forms containing hydroxyzine should be administered.

For children over 6 years, starting at 15-25mg and increasing to 50-100mg daily in divided doses adjusted according to the child’s weight.

As with all medications, the dosage should be adjusted according to the patient’s response to therapy.

Hepatic impairment

The total daily dose should be reduced by 33%. Use in patients with severe liver disease should be avoided (see Section ‘Special Warnings and Precautions for Use’)

Renal impairment

For patients with moderate or severe renal impairment, it is recommended that the total daily dosage should be reduced by 50% (see Section ‘Special Warnings and Precautions for Use’).

 

Method of administration: oral.

Pharmacological properties

Pharmacotherapeutic group: Anxiolytics

ATC code: N05B B01

Pharmaceutical particulars

List of excipients

Tablet core:

Microcrystalline cellulose,

lactose monohydrate,

calcium hydrogen phosphate,

sodium starch glycolate,

povidone K30,

magnesium stearate,

aerosil.

Tablet coating:

Hypromellose,

titanium dioxide,

propylene glycol,

talc.

For more detailed information about the drug, click: http://pharm.cals.am/pharm/data/drug_134425/1736329537406.pdf